tirzepatide does (Zepbound) for weight loss Tirzepatide Dosing - A Patient

Available in three strengths, this orange-flavored GLP-1 may be the right choice for patients who want to avoid injections

Based on the SURPASS-2 trial, tirzepatide, when taken once a week in doses of 10 or 15 mg, is more effective in reducing blood pressure than semaglutide, which is taken once a week in a dose of 1 mg

That is a 20-40% dosing error at the 0.5 mg level

Each named dose 2.5, 5, 7.5, 10, 12.5, 15 mg corresponds to a documented step

The bottom line Tirzepatide (same active ingredient as Mounjaro and Zepbound) is an FDA-approved injectable weight loss medication

A total of 60% were Hispanic or Latino ethnicity